We all know the importance of E4 to Mayne, When it was finally approved by FDA and is to be in production by June end, we are expecting CEO to update the market, not only the approval, but also the financial impact to the company. And yet, CEO is deadly quite on that point.
So the board and ceo have to be swept before the SP can gain a consistent upward move.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$4.95 |
Change
-0.200(3.88%) |
Mkt cap ! $402.1M | |||
| Open | High | Low | Value | Volume |
| $5.05 | $5.09 | $4.93 | $824.9K | 165.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16429 | $4.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.08 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| MYX (ASX) Chart |